Jessica Murphy presented at ISCT, International Society for Cell & Gene Therapy Houston Regional meeting on September 10, 2023, her well received poster and podium presentation of “ALLOGENEIC, LEUKOPHERESIS-DERIVED, VIRUS-SPECIFIC T CELL THERAPY FOR BK …
Uncategorized
McCoy, Kimple secure NIDCR funding for MSG MSCs for Xerostomia
UW Program for Advanced Cell Therapy partners Sara McCoy and Randall Kimple secure a new $297,680 National Institute of Dental and Craniofacial Research (NIDCR) R34 award to develop MSG MSC for xerostomia. Entitled “Planning a phase I study of minor salivary gland …
PACT Cell Manufacturing Specialist Presenting at ISCT Regional Meeting
UW Program for Advanced Cell Therapy (PACT) team member Jessica Murphy, MLS, has been selected as an Oral Abstract Presenter at the upcoming ISCT, International Society for Cell & Gene Therapy North America 2023 Houston Meeting, Sept 8-10 https://lnkd.in/ghq84Wsj, …
Testing a promising treatment for radiation-induced dry mouth
When Lee Marks and his wife were preparing for a trip to Europe in September 2019, the couple bought a thrift store suitcase to fill with nutritional shakes. At the time those shakes were the …
FDA approves IND for PACT study for Sjögren’s disease
First precision cell therapy targeting dry mouth as seen in Sjögren’s disease and graft-versus-host disease. Today, we are announcing that the University of Wisconsin-Madison School of Medicine and Public Health in partnership with the UW Carbone Cancer Center received …
PACT’s XRT trial activated by NIDCR
UW Program for Advanced Cell Therapy is the sponsor of a #MSC phase I trial led by Randall Kimple seeking to reverse radiation-therapy induced xerostomia. This investigator-initiated trial is funded through National Institute of Dental and Craniofacial Research (NIDCR). The Wisconsin …
UW IRB Approves Phase I Trial for XRT for Head and Neck Cancer
New Phase I clinical trial to treat subjects with xerostomia after XRT for Head and Neck Cancer gets green light from University of Wisconsin-Madison IRB. A new clinical trial covered under an IND held by UW Program for …
PACT Secures FDA approval for Xerostomia Pilot Study
UW Carbone Cancer Center secures FDA go-ahead for Contralateral submandibular gland #msc injection for Pilot Study (NCT04489732) subjects, if interested, who have already received MSCs in one submandibular gland to treat radiation-induced xerostomia A UW Program for Advanced Cell …
PACT Manufacturing Team presents at UWCCC Research Retreat
UW Program for Advanced Cell Therapy professionals Olga Ganz, Ross Meyers and Jessica Murphy authored a presentation for the April 5 2023 UW Carbone Cancer Center scientific retreat highlighting the feasibility of UW Health place-of-care (POC) #gmp manufacture of refreshed autologous bone marrow #mscs for #regenerativemedicine therapy applications. This lead use-case of …
UW Program for Advanced Cell Therapy Director of Cell Manufacturing secures membership to UW Carbone Cancer Center
On March 17, 2023, Ross Meyers, PhD, secured associate membership within the UW Carbone Cancer Center in the UW School of Medicine and Public Health. He has been appointed as a member of the UWCCC’s …